IF YOU OR SOMEONE YOU KNOW HAS DRY AGE-RELATED MACULAR DEGENERATION, LEARN ABOUT THE VALEDA LIGHT DELIVERY SYSTEM – NOW AVAILABLE

Contact us today to see if Valeda is right for you
Tel: (859) 263-3900 extension 144
Toll Free: (800) 627-2020 extension 144

About Valeda

Valeda is the first and only FDA authorized treatment device for Dry Age-Related Macular Degeneration (Dry AMD). Valeda treats AMD using Photobiomodulation (PBM), to apply specific wavelengths of light to the eye, stimulating mitochondrial energy activity within the cells of the eyes and improving their ability to perform their roles. Clinical studies have shown that Valeda can improve visual outcomes.

What to Expect?

At the initial assessment, a routine retinal examination with imaging is performed to verify that you are suitable for treatment. Follow-up retinal examinations with imaging will occur following your last treatment in each cycle.

The Treatment Course

Typically consists of three cycles annually, four months apart. Nine treatment sessions spread over a 3-5-week period typically make up one treatment cycle.

Treatment lasts less than 5 minutes on each eye. The treatment is safe, non-invasive, and generally pain free. There is no down-time required following treatment.

What Happens After?

A follow-up retinal examination with imaging is performed after your last treatment in each cycle.

Does Insurance Cover Valeda?

Valeda is not covered by insurance; however, you may be eligible for reimbursement through your Flexible Spending Account (FSA) or Health Savings Account (HSA). Please contact your insurance.

Learn more about Macular Degeneration (AMD).